You J, Zhu S, Li J, Li J, et al. High-dose versus standard-dose intensity-modulated radiotherapy with concurrent paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: a randomized, multicenter, open-label, phase 3 superiority trial. Int J Radiat Oncol Biol Phys 2022 Nov 16:S0360-3016(22)03520.
PMID: 36402359